Should You Be Confident in Merit Medical Systems’ (MMSI) Long-Term Outlook?

Core Insights - Carillon Tower Advisers reported a continued upward trend in equity markets, driven by AI advancements, reduced inflation from tariffs, and potential interest rate cuts by the U.S. Federal Reserve [1] - The Russell 2000® Growth Index increased by 12.19% in Q3 2025, slightly underperforming the Russell 2000 Value Index, which rose by 12.60% [1] Company Overview: Merit Medical Systems, Inc. - Merit Medical Systems, Inc. specializes in single-use medical devices for various medical procedures, including cardiology and oncology [3] - The company's stock experienced a decline of 0.53% over the past month and a significant drop of 13.67% over the last 52 weeks, closing at $82.79 per share with a market cap of $4.903 billion on October 28, 2025 [2] Financial Performance - In Q2 2025, Merit Medical reported revenues of $382.5 million, reflecting a 13% year-over-year increase on a GAAP basis and a 12.5% increase on a constant currency basis [4] Challenges and Outlook - The stock's decline was attributed to a reimbursement application misstep for the new WRAPSODY product, delaying its revenue contribution and potentially impacting margins [3] - Despite short-term challenges, the company maintains a positive long-term outlook [3] - Merit Medical is not among the top 30 most popular stocks among hedge funds, with 26 hedge fund portfolios holding its stock at the end of Q2 2025, an increase from 24 in the previous quarter [4]